Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

Shares of Dr. Reddy's Laboratories are trading 4.6% higher on Monday at ₹1,413.1. The stock has gained 8.5% so far in the month of June, which has turned out to be its best month since December 2024, ...

South Korea's exports of pharmaceuticals surpassed US$10 billion for the first time last year, while production of such ...

Biologic medicines have transformed the treatment of numerous serious disorders. Biosimilars, offering comparable safety and efficacy at a fraction of the cost, have driven significant healthcare ...

An USFDA inspection conducted between June 16 to June 25, 2026 resulted in the issuance of the Form-483 with seven ...

The proposed changes are relatively modest, yet they represent an important procedural step forward in the implementation of ...

On June 16, 2025, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule, “Medicare Drug Price Negotiation Program and ...

SmithRx, a modern pharmacy benefits manager (PBM), today announced an integration with Transcarent, the One Place for Health and Care™, that brings SmithRx's prescription drug cost intelligence and ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...

The business and financial sectors in the Gwangju region have welcomed the government, Samsung Electronics, and SK hynix’s plan to invest in a Southwe ...

A June inspection now has the FDA hitting Dr. Reddy’s with a Form 483, with seven observations spotted at its Indian biologics plant in Hyderabad during a site visit that wrapped up this week. The ...

NetRise today announced a partner-led managed software supply chain risk management offering for the federal market. Delivered through trusted federal integrators and managed service providers, the ...